| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC5126 | Thidiazuron | Highly efficient bioregulator of plant morphogenesis in the tissue culture technique, inducing diverse responses ranging from induction of callus to embryogenesis or organogenesis, acting through modulation of the endogenous plant growth regulators, modif |
|
| DCC5127 | Thielocin B1 | Novel protein-protein interaction inhibitor of PAC3 homodimer |
|
| DCC5128 | Thiobenzanilide 63t | Novel selective anticancer agent, selectively inducing cancer cell death in a caspase independent pathway |
|
| DCC5129 | Thiocrom-31 | First-in-class potent, selective, reversible, and tight binding inhibitor of human monoamine oxidase B (hMAO-B) (hMAO-B IC 50 = 1.52 ± 0.15 nM) |
|
| DCC5130 | Thioguanine-18 | Novel potent DENV2-NS2B/NS3pro inhibitor |
|
| DCC5131 | Thioluciferin | Firefly luciferin analog as a key element of bioluminescent reporters for oxidation state and thiol/disulfide equilibria |
|
| DCC5132 | Thiomuscimol Hydrobromide | GABAA receptor agonist |
|
| DCC5133 | Thiowurtzine | Novel Potent Inhibitor of the Opioid Receptors and the Ion Channels |
|
| DCC5134 | Thioxodihydroquinazolinone-19 | Novel inducer of apoptotic cell death in platinum-resistant A2780cis human ovarian cancer cells, exhibitong a strong inhibitory effect in ovarian CSC-LCs in combination with cisplatin |
|
| DCC5135 | Thiq-20c | Steroidomimetic and Chimeric Microtubule Disruptor |
|
| DCC5136 | Thk-523 | Selective Tau ligand, selectively binding to neurofibrillary tangles and neuropils in people with Alzheimer's disease |
|
| DCC5137 | Th-pf01 | Novel orthosteric-allosteric dual inhibitor of PfHT1 as selective antimalarial agent |
|
| DCC5138 | Th-pf02 | Novel orthosteric-allosteric dual inhibitor of PfHT1 as selective antimalarial agent |
|
| DCC5139 | Th-pf03 | Novel orthosteric-allosteric dual inhibitor of PfHT1 as selective antimalarial agent |
|
| DCC5140 | Thpp-11f | Novel potent, highly selective and orally available PI3Kδ inhibitor |
|
| DCC5141 | Thpp-2 | Novel phosphodiesterase 10A (PDE10A) inhibitor for treatment of schizophrenia |
|
| DCC5142 | Thpp-4 | Phosphodiesterase 10A (PDE10A) inhibitor |
|
| DCC5143 | Thr101 | Novel dose-dependent inhibitor of HDAC1, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, and HDAC9; NOX Inhibitor |
|
| DCC5144 | Thrombin-in-3g | Novel selective thrombin inhibitor, inducing conformational allostery |
|
| DCC5145 | Thrx160209 | Novel multivalent ligand that bridges the allosteric and orthosteric binding sites of the M2 muscarinic receptor |
|
| DCC5146 | Tiagabine | Anti-epileptic and anticonvulsant agent, acting as a selective GABA reuptake inhibitor |
|
| DCC5147 | Tiancimycin | Anthraquinone-fused enediyne antitumor agent for development of antibody-drug conjugates (ADCs) |
|
| DCC5148 | Tiemonium Iodide | Muscarinic receptor antagonist, anticholinergic,and parasympatholytic |
|
| DCC5149 | Tigilanol Tiglate | Natural anticancer agent fortreatment of mast cell tumor (MCT) |
|
| DCC5150 | Tillman Reagent | Widely used oxidation-reduction indicator |
|
| DCC5151 | Tilmicosin Phosphate | Macrolide antibiotic for the treatment of bovine respiratory disease and ovine respiratory disease associated with Mannheimia (Pasteurella) haemolytica |
|
| DCC5152 | Tilorone Dihydrochloride | Antiviral, antineoplastic, and anti-inflammatory agent; Orally active interferon inducer, inhibiting Ebola virus (EBOV) |
|
| DCC5153 | Tinostamustine Hydrochloride | Novel pan-histone-deacetylase inhibitor with alkylating activity |
|
| DCC5154 | Tinyatoxin | Neurotoxin, acting via vanilloid receptors of sensory nerves |
|
| DCC5155 | Tioxolone | Novel hepcidin antagonist |
|
